Keratin 19 (KRT19) (Middle Region) Peptide
KRT19
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all Cytokeratin 19 (KRT19) products
- Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- DMRSQYEVMA EQNRKDAEAW FTSRTEELNR EVAGHTEQLQ MSRSEVTDLR
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-KRT19 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeat freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
- Background
-
KRT19 involved in the organization of myofibers. Together with KRT8, KRT19 helps to link the contractile apparatus to dystrophin at the costameres of striated muscle.
Alias Symbols: CK19, K19, K1CS
Protein Size: 400 - Molecular Weight
- 44 kDa
- Gene ID
- 3880
- NCBI Accession
- NM_002276, NP_002267
- UniProt
- P08727
-
You are here:
